CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 28 enrolled
Drug / intervention
CLEAR + BRILLIANT TOUCH(R) 1440-nm and 1927-nm handpieces.device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05027282
NCT05027282N/ACompleted
CompareCT.gov

A Prospective Study Evaluating the Safety and Effectiveness of the CLEAR + BRILLIANT TOUCH(R) Diode Laser 1440-nm and 1927-nm Combination Wavelength Treatment.

Bausch Health Americas, Inc.·interventional·Posted Aug 30, 2021·Updated Nov 22, 2023

In Brief

A clinical study evaluating CLEAR + BRILLIANT TOUCH(R) 1440-nm and 1927-nm handpieces. for Photoaging. Completed, enrolled 28 participants across 1 site.

Detailed Summary

This is a prospective study of up to 30 subjects designed to assess the safety and effectiveness of a non-ablative fractional laser combination wavelength treatment for general resurfacing of photoaged skin. All study subjects will be treated on the whole face with the CLEAR + BRILLIANT TOUCH(R) 1440-nm and 1927-nm handpieces. Subjects will be treated with a consecutive series of four (4) treatments spaced 1 month apart, along with follow-up study visits at one (1) and three (3) months after final treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPhotoaging
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedAug 30, 2021
Enrollment StartOct 27, 2021
Primary CompletionNov 18, 2022
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 4.8 years ago

Interventions

CLEAR + BRILLIANT TOUCH(R) 1440-nm and 1927-nm handpieces.device

CLEAR + BRILLIANT TOUCH(R) diode laser 1440-nm and 1927-nm Combination Wavelength Treatment.